Articles dans des revues avec comité de lecture (368)
286.
De Bruyn, C., Stryckmans, P., Bron, D., Ley, P., Degueldre, M., & Delforge, A. (1993). Modulation of the growth of hematopoietic human stem cells by growth factors: comparison of umbilical cord blood with bone marrow. Journal of hematotherapy, 2(2), 241-242.287.
Bron, D., Debusscher, L., Bernier, M., Badjou, R., Crombez, P., & Stryckmans, P. (1992). L'autogreffe de moelle dans les hémopathies malignes. L'équipe de l'Unité Stérile. Revue médicale de Bruxelles, 13(5), 167-171.288.
Bieva, C., Martiat, P., Ferster, A., Sariban, E., Kedar, A., Erdos, G., Bron, D., Debusscher, L., & Stryckmans, P. (1992). Autologous bone marrow transplantation for acute leukemia using ferromagnetic microparticles and monoclonal antibody-purged marrows: demonstration of effectiveness by polymerase chain reaction. Progress in clinical and biological research, 377, 197-204.289.
Razavi, D., Delvaux, N., Bredart, A., Paesmans, M., Debusscher, L., Bron, D., & Stryckmans, P. (1992). Screening for psychiatric disorders in a lymphoma outpatient population. European journal of cancer, 28, 1869-1872.290.
Dancescu, M., Rubio-trujillo, M., Biron, G., Bron, D., Delespesse, G., & Sarfati, M. (1992). Interleukin-4 protects chronic lymphocytic leukemic B cells from death by apoptosis via the upregulation of Bcl-2 expression. The Journal of experimental medicine, 176(5), 1319-1326. doi:10.1084/jem.176.5.1319291.
Bron, D., Debusscher, L., Bernier, M., Badjou, R., Crombez, P., & Stryckmans, P. (1992). L'autogreffe de moelle dans les hémopathies malignes. Revue médicale de Bruxelles, 13, 167-171.292.
Bron, D., Lagneaux, L., Delforge, A., Otte, C., Snoeck, R., & Stryckmans, P. (1991). Prevention of CMV-induced myelosuppression by anti-CMV antibodies: an in vitro model. Experimental hematology, 19(2), 132-135.293.
Richard, V., Bernier, M., Themelin, L., Bron, D., & Sculier, J.-P. (1991). Blood coagulation abnormalities during adoptive immunotherapy with interleukin-2(r-Met Hu IL-2 (ala 125)). Annals of oncology, 2, 67-68.294.
Henry-Amar, M., Friedman, S., Hayat, M., Somers, R., Meerwaldt, J. H., Carde, P., Thomas, J., Monconduit, M., Noordijk, E. M., Bron, D., Regnier, D., De Pauw, B., Tanguy, A., Cosset, J., Dupouy, N., & Tubiana, M. (1991). Erythrocyte sedimentation rate as predictive factor for early relapse and survival in 772 EORTC patients with early stage Hodgkin disease. Annals of internal medicine, 114(5), 361-365.295.
Carde, P., Meerwaldt, J. H., van Glabbeke, M., Somers, R., Monconduit, M., Thomas, J., De Wolf, C., De Pauw, B., Tanguy, A., Kluin-Nelemans, H. C., Noordijk, E. M., Regnier, R., Bron, D., Marechal, J., Caillou, B., Bosq, J., Van Heerde, P., Van Unnik, J., Burgers, J., Hayat, M., Cosset, J., Van der Schueren, E., Wagener, J., Hagenbeek, A., Cattan, A., Duez, N., & Tubiana, M. (1991). Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high-grade non-Hodgkin's lymphoma (NHL): the 1980-1985 EORTC trial. Annals of oncology, 2(6), 431-436.296.
Delforge, A., Bernier, M., Bosmans, E., Massy, M., Bron, D., Heyligen, H., Raus, J., Mendes da Costa, P., & Stryckmans, P. (1991). Measurement of soluble interleukin 2 receptor in sera of adult patients with hematological or solid malignancies. Leukemia & lymphoma, 3, 385-393.297.
Philip, T., Chauvin, F., Armitage, J., Bron, D., Hagenbeek, A., Biron, P., Spitzer, G., Weisenburger, D., Fernandez-Ranada, J., Somers, R., Rizzoli, V., Harousseau, J., Sotto, J., Cahn, J.-Y., Guilhot, F., Biggs, M. J., Sonneveld, P., Misset, J., Manna, A., Jagannath, S., Guglielmi, C., Chevreau, C., Delmer, A., Santini, D., & Coiffier, B. (1991). Parma international protocol: pilot study of DHAP followed by involved field radiotherapy and BEAC with autologous bone marrow transplantation. Blood, 77, 1587-1592.